United States · Federal contract register · Supplier record

GALVANIZE THERAPEUTICS, INC.

Line: Medical and surgical instruments, equipment, and supplies (6515)Register loaded to November 2025Compiled 17 October 2026

GALVANIZE THERAPEUTICS, INC. — United States · Federal contract register · Supplier record: 13 contracts, all years ($1,309,933 · Feb 2023 – Sep 2026); $897K since January 2024 (9 contracts · 2 agencies); 506th rank in the line (of 3,402 suppliers · 0.01%); 21 agencies never served ($209M on the line without GALVANIZE THERAPEUTICS, INC.).

Assay record ASY-US-0VUK7W21Y5 · Cite as: Assay Systems, “GALVANIZE THERAPEUTICS, INC.: 9 government contracts in the United States since 2024”, https://assay-systems.com/register/us/galvanize-therapeutics-inc/

13
contracts, all years
$1,309,933 · Feb 2023 – Sep 2026
$897K
since January 2024
9 contracts · 2 agencies
506th
rank in the line
of 3,402 suppliers · 0.01%
21
agencies never served
$209M on the line without GALVANIZE THERAPEUTICS, INC.

Own record by year

2023 onward
$413K
$224K
$416K
$257K
2023202420252026

Who buys from GALVANIZE THERAPEUTICS, INC.

since January 2024
2agencies
$897Kpaid
95.9%top buyer
Department of Veterans Affairs95.9%
$859,925
Department of Health and Human Services4.1%
$37,125

Won without a rival

2024-01-08 – 2026-09-17
9uncontested awards
100%of its awards
8without a competition
1single bid

GALVANIZE THERAPEUTICS, INC won 9 of its 9 public contract awards in United States without a rival from 2024-01-08 to 2026-09-17, worth $897K: 8 without a competition and 1 after a competition that drew a single bid. 2 buyers awarded it without a rival, the largest Department of Veterans Affairs with 8.

Buyers: Department of Veterans Affairs (8) · National Institutes of Health (1)

Every uncontested award of GALVANIZE THERAPEUTICS, INC · United States: all uncontested awards

The line

since January 2024
$6.8Bline value
80,701contracts
23agencies
3,402suppliers
49.8%held by top ten

Medical and surgical instruments, equipment, and supplies (6515)

$3.6B
$3.2B
20242025Jan–Nov
506thof 3,402 suppliers
$639,925GALVANIZE THERAPEUTICS, INC. in the line
0.01%share of the line
0.0%of $6,257,326,526 spent by Department of Veterans Affairs
0.0%of $338,843,344 spent by Department of Health and Human Services

Agencies that buy the line and never bought from GALVANIZE THERAPEUTICS, INC.

21agencies
33,377contracts
$208,928,257since January 2024
Department of Defense31,967 contracts
$144,969,335
Department of Justice712 contracts
$28,313,586
Department of Homeland Security133 contracts
$13,728,176
Department of State221 contracts
$11,211,675
General Services Administration180 contracts
$2,744,995
Department of Agriculture27 contracts
$1,595,505
Department of the Treasury55 contracts
$1,209,012
Department of Commerce19 contracts
$1,093,499
Department of the Interior18 contracts
$1,024,057
National Aeronautics and Space Administration11 contracts
$934,078
Peace Corps5 contracts
$487,383
Department of Labor2 contracts
$375,245
Social Security Administration5 contracts
$369,405
Agency for International Development3 contracts
$314,517
Department of Transportation7 contracts
$215,289
Environmental Protection Agency3 contracts
$153,913
Smithsonian Institution2 contracts
$79,007
Court Services and Offender Supervision Agency1 contract
$68,158
National Labor Relations Board1 contract
$15,462
Equal Employment Opportunity Commission1 contract
$14,718
National Archives and Records Administration4 contracts
$11,242

How the line is bought

by value, since 2024
40%no competition
13%one applicant
0of these to GALVANIZE THERAPEUTICS, INC.
Competed, several suppliers applied38,797 contracts
$3,244,417,358 · 47.7%
Awarded directly, no competition23,763 contracts
$2,692,692,280 · 39.6%
Competed, one supplier applied18,141 contracts
$867,988,489 · 12.8%

Contracts reaching their end dates

Oct 2026 – October 2027
397contracts
$406,086,347end by October 2027
80end in December 2026 · $30.0M
18in agencies never served · $4.6M
$47.7M
$13.2M
$30.0M
$15.9M
$13.0M
$27.3M
$2.8M
$12.2M
$13.5M
$16.6M
$46.8M
$167M
$36.3K
Oct 2671 contractsNov 2638 contractsDec 2680 contractsJan 2724 contractsFeb 2720 contractsMar 2729 contractsApr 2713 contractsMay 2710 contractsJun 2715 contractsJul 2724 contractsAug 2723 contractsSep 2748 contractsOct 272 contracts

Suppliers next to it in the line

since January 2024
TERUMO BCT INC3 contracts · 3 agencies
$643,277
RLN ENTERPRISES INC34 contracts · 1 agency
$641,768
GALVANIZE THERAPEUTICS, INC.
$639,925
PICIS CLINICAL SOLUTIONS, INC.5 contracts · 1 agency
$639,635

All 3,402 suppliers in the line

Fastest-growing supplier in the line

same line
+63%growth

Supplier UEI DMPAKJ9N9K66

2024 to Nov 2025
$946,119,208
2022–2023
$580,462,978

The extract

Every buying office, every contract holder, value, number and end date behind the figures above.

Request extractSee a sample extract

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.